For citations:
Romanov I.S., Mudunov A.M., Isaev P.A., Bychkov Yu.M., Dolgushin M.B., Odzharova A.A., Romanova L.F. LENVATINIB IN TREATMENT OF RADIOACTIVE IODINE-REFRACTORY WELL-DIFFERENTIATED THYROID CARCINOMA. Head and Neck Tumors (HNT). 2017;7(2):45-52. (In Russ.) https://doi.org/10.17650/2222-1468-2017-7-2-45-52
Email this article 